Guangdong Taiantang Pharmaceutical Co.Ltd(002433) independent director
On relevant matters of the 33rd meeting of the 5th board of directors of the company
Prior approval opinion
In accordance with the company law of the people’s Republic of China, No. 1 self regulatory guidelines for listed companies of Shenzhen Stock Exchange – standardized operation of listed companies on the main board, the articles of association and the working system of independent directors and other relevant provisions, we are independent directors of Guangdong Taiantang Pharmaceutical Co.Ltd(002433) (hereinafter referred to as ” Guangdong Taiantang Pharmaceutical Co.Ltd(002433) ” or “the company”), We hereby express our prior opinions on the relevant matters to be submitted to the 33rd meeting of the Fifth Board of directors of the company for deliberation as follows:
This guarantee of the company is conducive to the normal business operation of kangaido. When the company provides guarantee for kangaido suppliers, Mr. Ke Shuquan and Mr. Ke Shaobin shall provide guarantee in the same proportion according to their shares. This guarantee is in line with the company’s development plan and the overall interests of the company, and there is no damage to the interests of the company and shareholders, especially small and medium-sized shareholders.
In conclusion, we agree to submit this guarantee to the 33rd meeting of the 5th board of directors for deliberation. (there is no text on the next page, which is the signature page of the company’s independent directors’ prior opinions on matters related to the 33rd meeting of the Fifth Board of directors)
(there is no text on this page, which is the signature page of the company’s independent directors’ prior opinions on matters related to the 33rd meeting of the Fifth Board of directors) signature of the independent directors:
Wang Guihua, Nie Zhijin, Liu Li
February 18, 2002
